Ofranergene obadenovec Uses, Dosage, Side Effects and more
Ofranergene obadenovec is under investigation in clinical trial NCT01229865 (Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer).
| Trade Name | Ofranergene obadenovec |
| Generic | Ofranergene obadenovec |
| Ofranergene obadenovec Other Names | Ofranergene obadenovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
